FDA Investigator Jose R Lopez

Jose R Lopez has conducted inspections on 45 sites in 4 countries as of 30 Jun 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
45
Last Inspection Date:
30 Jun 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Puerto Rico, Ireland, United Kingdom of Great Britain and Northern Ireland, Poland
FDA Investigators that have inspected at least one site in common with Jose R Lopez:
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alicia M Mozzachio, An T Vu, Anastasia M Shields, Andrea George, PhD, Angelica M Hernandez, Ann L Demarco, Annette Melendez, Ariel Cruz Figueroa, Arlene M Badillo, Ashley N Queen, PhD, Brenda Rivera, Brian J Ryan, Calvin B Koerner, Carlos A Medina, Carlos Arivera Ramirez, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charisse K Green, Chelsea N Sealey, Cheryl A Clausen, Christopher Downey, PhD, Colleen F Hoyt, Colleen Thomas, PhD, Dayna I Martinez, Debra I Love, Dennis Cantellops Paite, Devaughn Edwards, Dewayne E Whitlock, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dorota Matecka, PhD, Douglas A Campbell, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Edwin Martinez, Eliezar Ramos, Erika V Butler, Eva I Merced Medina, Frances L Dejesus, Frederick L Fricke, George J Flynn, German Rivera, Hector Espinet, Hector Jcolon Torres, Iraida Ortiz, Ivis L Negron, Ivonne A Vicente, Jaime E Pares, Javier O Vega, Jennifer A Quinones, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Joe X Phillips, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose A Moreno, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Martinez, Jr, Jose Perez Soto, Jose Rflores Veguilla, Jose Velez, Juan Rjimenez Garcia, Karl D Hezel, Kathryn E Ogger, Laiza V Garcia, Laura E Garcia, Laurimer Kuilan Torres, Libia M Lugo, Lisa M Lopez, Lizaida E Rodriguez, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Luis O Rodriguez, LT Rafael Gonzalez, Luis A Carrion, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marian E Ramirez, Marianela Aponte Cruz, Maribel V Juarbe, Marie T Falcone, Marilyn Santiago, Marisol Faberlle, Mark R Mcclain, Marlene Rodriguez Colon, Marta E Gonzalez, Maxwell Van Tassell, PhD, Medina, Michael A Charles, Michael E Maselli, Michael Levy, Michael R Klapal, Michael Shanks, MS, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Mihaly S Ligmond, Milva E Melendez Perales, Min Tang, Minerva Rogers, Mra Davism, Muralidhara B Gavini, PhD, Myriam M Sosa, Nancy Rosado, Nicholas Obiri, PhD, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul A Bonneau, Paul Z Balcer, Paula A Trost, Philip F Istafanos, DMV, MS, Rafael E Arroyo, Rafael E Cruz, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Regina T Brown, Riley C Myers, PhD, Robert D Tollefsen, Robert Darius, Russell J Glapion, Ruth Moore, PhD, Saied A Asbagh, Sandra Carpio, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Shirley J Berryman, Simone E Pitts, Sixto M Mercado Rios, Sonia M Monges, Stacie A Woods, Stephanie D Crockett, Steven B Barber, Steven C Madzo, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Susan P Bruederle, Susanna E Ford, Tajah L Blackburn, Thao T Kwan, Thomas J Arista, Tiara Nbrown Crosen, Timothy Wadkin, PhD, Victor S Pacheco, Vilmary Negron Rodriguez, Walden H Lee, Wanda J Torres, Wendy G Tan, PhD, Zachary L Stamm, Zhong Li, PhD, Zhongren Wu

Jose R Lopez's Documents

Publish Date Document Type Title
July, 2013 FDA 483 IPR Pharmaceuticals, Inc - Form 483, 2013-07-29
March, 2013 FDA 483 Neolpharma, Inc. - Form 483, 2013-03-07
May, 2010 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2010-05-04
September, 2011 FDA 483 Gasco Industrial - Form 483, 2011-09-21
May, 2009 FDA 483 Janssen Ortho LLC - Form 483, 2009-05-11
March, 2014 FDA 483 Ex-Lax, Inc. - Form 483, 2014-03-05
March, 2010 FDA 483 Dentsply Prosthetics - Form 483, 2010-03-18
October, 2012 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2012-10-22
June, 2012 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2012-06-29
April, 2013 FDA 483 Auro PR Inc. - Form 483, 2013-04-24
August, 2011 FDA 483 Brisas del Caribe Corp. - Form 483, 2011-08-12
September, 2012 FDA 483 TAPI Puerto Rico, Inc. - Form 483, 2012-09-18
June, 2012 EIR Boehringer Ingelheim Animal Health Puerto Rico LLC - EIR, 2012-06-20
November, 2014 EIR PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC - EIR, 2014-11-17
August, 2010 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2010-08-13
November, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-11-02
November, 2010 FDA 483 McNeil Healthcare, LLC - Form 483, 2010-11-02
March, 2014 FDA 483 Pfizer Pharmaceuticals LLC - Form 483, 2014-03-11
October, 2012 EIR Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - EIR, 2012-10-22
June, 2012 EIR TAPI Puerto Rico, Inc. - EIR, 2012-06-29
November, 2014 FDA 483 PF Consumer Healthcare B.V. (Puerto Rico Operations) LLC - Form 483, 2014-11-17
March, 2014 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2014-03-11
July, 2013 EIR IPR Pharmaceuticals, Inc - EIR, 2013-07-29
June, 2011 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2011-06-15
April, 2011 EIR Amgen Manufacturing Limited LLC - EIR, 2011-04-29
April, 2011 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2011-04-29
April, 2012 FDA 483 VWR Advanced Instruments, LLC - Form 483, 2012-04-03
April, 2012 EIR VWR Advanced Instruments, LLC - EIR, 2012-04-03
October, 2011 FDA 483 McNeil Healthcare LLC. - Form 483, 2011-10-26
January, 2009 FDA 483 Galephar Pharmaceutical Research Inc - Form 483, 2009-01-30
June, 2012 FDA 483 Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483, 2012-06-20
January, 2010 FDA 483 McNeil Healthcare LLC. - Form 483, 2010-01-08
April, 2013 EIR Auro PR Inc. - EIR, 2013-04-24
January, 2010 FDA 483 Response McNeil Healthcare LLC. - Form 483R, 2010-02-05
March, 2014 EIR Viatris Pharmaceuticals LLC - EIR, 2014-03-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more